Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

NCT01184833 · clinicaltrials.gov ↗

COMPLETED

Status

852

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Interferon beta-1b (Betaseron, BAY86-5046)

Sponsor

Bayer